US mRNA specialist Moderna today announced that the US Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345), ...

UK pharma major GSK today revealed that it has licensed its Shigella vaccine candidate, altSonflex1-2-3, to India’s Bharat ...

Novo Nordisk late Thursday announced that it will advance subcutaneous (SC) and oral amycretin into Phase III development in ...

Belgium’s largest drugmaker UCB has announced plans for a significant investment in a new, state-of-the-art biologics ...

The Russian pharmaceutical market is showing positive dynamics these days, despite the ever-tightening sanctions regime and ...

Novartis has unveiled further data for Fabhalta (iptacopan), reinforcing its position in the paroxysmal nocturnal ...

The American medicines regulator has approved Zusduri (mitomycin), a hydrogel-based treatment developed by US biotech UroGen ...

Russian drugmaker Axelpharm has managed to lift the ban on the launch of osimertinib - a drug, which is used in the treatment ...

COVID success story BioNTech (Nasdaq: BNTX) is to buy fellow German mRNA company CureVac (Nasdaq: CVAC). Shares in the latter ...

South Korea’s LigaChem Biosciences has signed two antibody licensing agreements with US biotech NovaRock Biotherapeutics, reports Korea Biomedical Review.

Research services company IQVIA has unveiled new AI agents built using NVIDIA technology that are designed to enhance ...

US biotech Novavax (Nasdaq: NVAX) has reported that its experimental combination COVID-19 and influenza vaccine generated ...